Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y, Chang Y, Wang Z, Chen L, Kong Y, Zhang P, Liu Z, Zhou Q, Chen Y, Wang J, Bai Q, Xia Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Wang Y, Xu J, Zhang W. Qi Y, et al. Among authors: zhou q. Cancer Immunol Immunother. 2019 Dec;68(12):2067-2080. doi: 10.1007/s00262-019-02429-2. Epub 2019 Nov 12. Cancer Immunol Immunother. 2019. PMID: 31720813 Free PMC article.
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients.
Xiong Y, Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Wang J, Chang Y, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Bai Q, Guo J, Xu J. Xiong Y, et al. Among authors: zhou q. J Immunother Cancer. 2020 Mar;8(1):e000447. doi: 10.1136/jitc-2019-000447. J Immunother Cancer. 2020. PMID: 32217761 Free PMC article.
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Qi Y, Xia Y, Lin Z, Qu Y, Qi Y, Chen Y, Zhou Q, Zeng H, Wang J, Chang Y, Bai Q, Wang Y, Zhu Y, Xu L, Chen L, Kong Y, Zhang W, Dai B, Liu L, Guo J, Xu J. Qi Y, et al. Among authors: zhou q. Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576. doi: 10.1007/s00262-020-02563-2. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306075 Free PMC article.
Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.
Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Zhu Y, Xu L, Dai B, Liu L, Guo J, Xu J. Wang Z, et al. Among authors: zhou q. Oncoimmunology. 2020 Apr 10;9(1):1747332. doi: 10.1080/2162402X.2020.1747332. eCollection 2020. Oncoimmunology. 2020. PMID: 32313725 Free PMC article.
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Wang T, Zhou Q, Zeng H, Zhang H, Liu Z, Shao J, Wang Z, Xiong Y, Wang J, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Chang Y, Wang X, Xu J. Wang T, et al. Among authors: zhou q. Cancer Immunol Immunother. 2020 Sep;69(9):1855-1867. doi: 10.1007/s00262-020-02583-y. Epub 2020 May 4. Cancer Immunol Immunother. 2020. PMID: 32367308 Free PMC article.
22,475 results
You have reached the last available page of results. Please see the User Guide for more information.